Please check your internet connection and try again.
# Hyoscine butylbromide
## Overview
Hyoscine butylbromide is an anticholinergic (antimuscarinic) medication that reduces gastrointestinal spasms and motility. It is a quaternary ammonium derivative of scopolamine, which limits its penetration into the central nervous system, thus reducing central anticholinergic side effects.
## Primary Indications
* Symptomatic relief of abdominal pain and cramps associated with gastrointestinal disorders, such as irritable bowel syndrome (IBS) and diverticulitis.
* Pre-operative medication to reduce secretions and prevent bradycardia during anesthesia.
* Management of spasms of the biliary and urinary tracts.
## Adult Dosing
* **Gastrointestinal spasms:** 10-20 mg orally three to five times daily, or 20 mg intramuscularly (IM) or intravenously (IV) every 4-6 hours as needed. Maximum daily oral dose is typically 100 mg. Maximum parenteral dose is typically 100 mg daily.
* **Pre-operative:** 0.4 mg IM administered approximately 30-60 minutes before surgery.
* **Biliary/Urinary spasms:** 20 mg IM or IV every 4-6 hours as needed.
## Pediatric Dosing
Dosing in pediatric populations is not well-established and should be approached with caution. Available data suggests:
* **Infants and children up to 12 years:** Generally not recommended due to lack of established safety and efficacy, especially in infants. Some sources suggest doses by weight for specific indications if deemed necessary by a clinician, but these are not universally standardized.
## Dose Adjustments
Dose adjustments are generally not required for renal or hepatic impairment, but caution is advised in severe cases.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Angle-closure glaucoma.
* Myasthenia gravis.
* Adynamic ileus or severe ulcerative colitis.
* Tachyarrhythmias.
* Prostatic hypertrophy with urinary retention.
* Cystic fibrosis (increased risk of adverse effects).
* Infants under 6 months of age (risk of ileus and urinary retention).
## Adverse Effects
Common adverse effects include dry mouth, blurred vision, constipation, difficulty urinating, drowsiness, and tachycardia. Less common effects include confusion, dizziness, and skin rash.
## Key Drug Interactions
* **Other Anticholinergics:** Additive anticholinergic effects.
* **Dopamine Antagonists (e.g., Metoclopramide):** May reduce the efficacy of both drugs.
* **Opioids:** May increase the risk of ileus.
* **Beta-blockers:** May exacerbate tachycardia.
* **Potassium supplements:** Oral potassium chloride can cause gastrointestinal ulceration; concurrent administration with anticholinergics that reduce motility may increase this risk.
## Monitoring
* Monitor for signs of anticholinergic adverse effects (e.g., dry mouth, blurred vision, urinary retention, constipation, confusion).
* Assess effectiveness in relieving abdominal pain and spasms.
## Clinical Pearls
* Hyoscine butylbromide provides symptomatic relief of spasms and pain but does not treat the underlying cause.
* Parenteral administration may be preferred for more rapid onset of action in acute colic.
* Use with caution in the elderly due to increased susceptibility to anticholinergic side effects.
**Disclaimer:** This information is intended for clinical professionals and is not a substitute for professional medical judgment. Always consult the most current prescribing information and local protocols before administering any medication.
